Cite
HARVARD Citation
Han, H. et al. (2021). A phase I clinical trial to evaluate the safety of HU‐045 for treating moderate‐to‐severe glabellar lines: a pilot study. Journal of the European Academy of Dermatology and Venereology. pp. e614-e617. [Online].